Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01908348 · ClinicalTrials.gov registry record · NA
Dose-Dependent Effects of Erythritol on Endothelial Function in Type 2 Diabetes Mellitus
A NA study, sponsored by Boston University.
- Completed
- Registry status
- NA
- Development phase
- 27
- Enrollment target
NCT01908348 is a NA study that has completed, run by Boston University. The registered enrollment target is 27 participants.
The verdict
NCT01908348, a NA study, has completed, sponsored by Boston University.
- COMPLETED
- Registry status
- NA
- Development phase
- 27 participants
- Enrollment target
Study Summary
This study is an open-label pilot designed to examine the dose-dependent effects of erythritol, a zero calorie sweetener, on endothelial function. Twenty-four subjects with type 2 diabetes mellitus will make three study visits. At each visit, the will consume an orange-flavored beverage containing escalating amounts of erythritol (6, 12, and 18 grams). Endothelial function will be assessed before and two hours after beverage consumption. Endothelial function will be measured as the change in pulse amplitude in response to reactive hyperemia measured in the fingertip by peripheral arterial tonometry. The results will be used to plan a randomized, placebo-controlled study.
Interventions
- DIETARY_SUPPLEMENT Erythritol
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 27 participants |
| Start Date | 2013-07-18 |
| Est. Completion | 2016-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01908348
The ClinicalTrials.gov registry entry for NCT01908348 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 27 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Boston University, which has 185 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Erythritol is the first listed.
NCT01908348 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01908348 about?
NCT01908348 is a clinical study titled "Dose-Dependent Effects of Erythritol on Endothelial Function in Type 2 Diabetes Mellitus". This study is an open-label pilot designed to examine the dose-dependent effects of erythritol, a zero calorie sweetener, on endothelial function. Twenty-four subjects with type 2 diabetes mellitus will make three study visits. At each visit, the will consume an orange-flavored beverage containing e...
What is the current status of trial NCT01908348?
This trial is currently completed. It is a NA study. The enrollment target is 27 participants. The study started on 2013-07-18. Estimated completion is 2016-12.
What interventions are being tested in trial NCT01908348?
The interventions under investigation include: Erythritol (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT01908348?
This trial is sponsored by Boston University, which has 185 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.